Furthermore, the inactivation of RASSF1A is often caused by hypermethylation of the promoter region, which allows the abnormal methylation of RASSF1A being more easily detected in a variety of cancers, including BC, lung cancer, and gastrointestinal cancer [31]. The gene discussed is RASSF1; the disease is breast cancer.